Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Jently vs Neo Soma Healthcare

Jently
Graded #170

Higher grade

vs+1.2000000000000028
Neo Soma Healthcare
Graded #213

Lower grade

The verdict

Jently takes it — 67/100 to 65.8/100, but only just.

Jently grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Jently is a clinician-guided telehealth service offering compounded GLP-1 weight management (semaglutide from $149/mo, tirzepatide from $199/mo) alongside NAD+, peptide therapy (sermorelin, glutathione),… Neo Soma Healthcare is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueJently +8
74
66
Dose & formulationNeo Soma Healthcare +8
64
72
Clinical oversightJently +7
79
72
Labs & monitoringNeo Soma Healthcare +10
52
62
FulfillmentJently +10
67
57
Contract termsNeo Soma Healthcare +4
51
55
Jently · left barNeo Soma Healthcare · right bar

The numbers

MetricJentlyNeo Soma Healthcare
WeighScore67/10065.8/100
GradeCC
Scorecard rank#170#213
Semaglutide$149/mo (starting dose, compounded)$199/mo
Tirzepatide$199/mo (starting dose, compounded)$330/mo
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Jently

Graded #170 · C

Strengths

  • Compounded semaglutide from $149/mo and tirzepatide from $199/mo — pricing published
  • Multi-pillar: GLP-1, NAD+, peptides (sermorelin, glutathione), and metformin
  • 100% online with licensed providers via the MD Integrations network
  • Subscription can be cancelled anytime through the patient portal

Where it loses points

  • Specific pharmacy partner not named on the site
  • No refunds once a consultation is completed or a prescription is dispensed
  • Not LegitScript-certified (no certification displayed)
  • States of operation not published
Neo Soma Healthcare

Graded #213 · C

Strengths

  • LegitScript verification badge present
  • Publishes the FDA compounded-medication disclaimer
  • Pricing shown publicly for all 6 product lines
  • Multi-product platform (GLP-1, sexual health, peptide therapies)
  • First-month discount on semaglutide ($99 entry)

Where it loses points

  • Pharmacy partner not named (503A vs 503B unclear)
  • States served not listed — no per-state availability table
  • No named medical director
  • Standard semaglutide pricing ($199/mo) above the cheapest providers ($150–180/mo)
  • Tirzepatide entry pricing ($330) above the cheapest providers (~$200–250/mo)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard